D2 G Oncology, Inc. reported raising $6.57 Million in an initial SEC Form D filing, from an offering of $7.25 Million
PRIVATEFeb 28, 2020
Amount Raised
$6.57 Million
$6.57 Million sold, per SEC Form D (first sale Feb 28, 2020)
Round Type
Venture
Mountain ViewBiotechnologyWho to call at D2G Oncology, Inc., and when
A new round usually means D2G Oncology, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day D2G Oncology, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at D2G Oncology, Inc., from your own LinkedIn network
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment D2G Oncology, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
D2G Oncology, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.